欧美成人电影av特级,一个色网站导航,王媛张刚全文免费阅读txt下载,久久91亚洲精品中文字幕,豆腐西施桃谷第一部在线观看,最新2024色色色

產(chǎn)品分類導(dǎo)航
Ginkgolide injection
Ginkgolide injection
Ginkgolide injection

Ginkgolide injection

更新時間:2024-05-18

價格:
地區(qū): 成都
是否提供樣品:
立即詢盤
收藏
產(chǎn)品詳情
產(chǎn)品關(guān)鍵詞: Ginkgolide injection,,
是否為生產(chǎn)商:
主要銷售市場: 北美洲,中/南美洲,西歐,東歐,大洋洲,亞洲,中東,非洲
產(chǎn)品描述:

Active ingredients: bilobalide, ginkgolide A, ginkgolide B and ginkgolide C.

Description: a colorless or pale-yellow clear liquid.

Dosage Form: liquid injection.
Indications: For mild to moderate cerebral infarction, symptoms are hemiplegia, deviated tongue, paralalia and paraesthesia, etc.
Strength: 2ml/ampoule, containing 10mg ginkgolide.

Storage: Keep airtight in a dark and cool place.

Packaging: ampoule, 5 ampoules/box (Can be customized based on customer's order.)

Shelf Life: 24months.
Dosage and Administration:
Administrated by intravenous infusion. The recommended dose is 5 bottles (10ml). Before use, add the powder into 250ml of 0.9% sodium chloride injection or 250ml of 5% glucose injection for dilution and administrated as a slow intravenous infusion. Give the dosage once a day; during the infusion, strictly control the rate ranging from 40 to 60 drops per minute. The course of treatment is 14 days.
Contradictions:
1. Patients with a history of hypersensitivity or adverse reaction to the product or any other finished ginkgo products.
2. Patients with a history of hypersensitivity to ethanol, glycerin, ethanol (alcohol) and glycerol.
3. Contradicted in pregnant and lactating women.
Pharmacology and toxicology:
The results of non-clinical pharmacodynamic study showed that the product can reduce the stroke score, the mortality rate and the cerebral infarction area in the rat  focal cerebral ischemia model using the suture method; can promote the recovery of  amplitude of EEG potential, can reduce cerebral ** content in the gerbil cerebral ischemia-reperfusion model; can reduce brain wet weight, brain index, cerebral ** content in the rat cerebral ischemia-reperfusion model using 4-vessel occlusion method, reduce the damage of hippocampal CA1 (increase the density of neuron in the region).

 

 

CDMO Service Undertaking

Dosage Form

Production Lines

Annual Capacity 

Injection

8

650,000,000

Oral Solid

3

700,000,000

API & Intermediates

3

8,000 Kg

TCM Extraction

2

5,000,000 Kg 

Baiyu provide CDMO service for:

FDFs & APIs
Primary & secondary packaging
Warehousing
Commercial scale, pilot scale, laboratory scale

You are warmly welcomed to contact us for business cooperation.

sales@baiyu.cn

Chengdu Baiyu Pharmaceutical Co., Ltd.

www.baiyujituan.com

四川宏明博思藥業(yè)有限公司
注冊資本不愿意公開
公司地址
成都高新區(qū)合作路343號
聯(lián)系人
聯(lián)系電話
聯(lián)系手機(jī)
查看聯(lián)系方式
快速詢盤
詢盤主題
請輸入詢盤主題
詢盤信息
請輸入詢盤信息
滑動驗證
請完成滑塊驗證
快速發(fā)送詢盤
CPHI制藥在線為您找到Ginkgolide injection 價格、Ginkgolide injection 詳細(xì)參數(shù)、Ginkgolide injection 相關(guān)產(chǎn)品、Ginkgolide injection 供應(yīng)商等信息,想了解當(dāng)前Ginkgolide injection 最新報價,請聯(lián)系四川宏明博思藥業(yè)有限公司。
2006-2024 上海博華國際展覽有限公司版權(quán)所有(保留一切權(quán)利) 滬ICP備05034851號-57
乐清市| 句容市| 利辛县| 高安市| 思南县| 白水县| 南丰县| 栾城县| 安塞县| 离岛区| 土默特右旗| 长丰县| 高平市| 洛隆县| 翁牛特旗| 利津县| 宜良县| 永城市|